Abstract
Since the mid-1980s, the family of high molecular weight glycoproteins known as mucins have evoked considerable interest among those in the field of cancer research. Mucins, which are constituents of mucus, have a lubricating and protective function in normal epithelial tissue (1). However, expression of mucin by the cancer cell is often highly disorganized and upregulated, sometimes to the extent that mucin can be detected in the circulation of the cancer patient. These changes in expression of mucin observed in neoplasia have led to the exploitation of some members of the mucin family as circulating tumor markers (2,3) or targets for diagnostic imaging (4–6) and therapy of cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allen A. (1983) Mucus-a protective secretion of complexity. TIBS. 8, 169–173.
Hayes D. F., Zurawski,Jr. V. R. and Kufe D. W. (1986) Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. J. Clin. Oncol. 4, 1542–1550.
Robertson J. F. R., Pearson D., Price M. R., Selby C., Blamey R. W., and Howell A. (1991) Objective measurement of therapeutic response in breast cancer using tumour markers. Br. J. Cancer 64, 757–763.
Perkins A. C., Symonds I. M., Pimm M. V., Price M. R., Wastie M. L., and Symonds E. M. (1993) Immunoscintigraphy of ovarian carcinoma using a monoclonal antibody (In-11 1-NCRC-48) defining polymorphic epithelial mucin. Nucl. Med. Commun. 14, 578–586.
Kunkler R. B, Bishop M. C., Green D. J., Pimm M. V., Price M. R., and Frier M. (1995) Targeting of bladder cancer with radiolabelled monoclonal antibody NCRC-48-a novel approach for intravesical therapy. Br. J. Urol. 75, 9–17.
Biasson L., Granowski M., Carroll M. J., Mather S. J., Howell R., Ellison D., MacNeil F. A., Wells C. A., Carpenter R. and Britton K. E. (1998) 99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection. Br. J. Cancer 77, 131–138.
Hudecz F. and Price M. R. (1992) Monoclonal antibody binding to peptide epitopes conjugated to synthetic branched chain polypeptide carriers. J. Immuol. Meth. 147, 201–210.
Geysen H. M., Rodda S. J., Mason T. J., Tirbbick G., and Schoofs P. J. (1987) Strategies for epitope analysis using peptide synthesis. J. Immunol. Meth. 102, 259–274.
Price M. R., Sekowski M., and Tendler S. J. B. (1991) Purification of anti-epithelial mucin monoclonal antibodies by epitope affinity chromatography. J. Immunol. Methods 139, 83–90.
Price M. R., Sekowski M., Hooi D. S. W., Durrant L. G., Hudecz F., and Tendler S. J. B. (1993) Measurement of antibody binding to antigenic peptides conjugated in situ to albumin coated microtitre plates. J. Immunol. Methods 159, 277–281.
Murray A., Sekowski M., Spencer D. I. R., Denton G. and Price M. R. (1997) Purification of monoclonal antibodies by epitope and mimotope affinity chromatography. J. Chromatog. A 782, 49–54.
Nishimori I., Perini F., Mountjoy K. P., Sanderson S. D., Johnson N., Cerny R. L., Gross M. L., Fontenot J. D., and Hollingsworth M. A. (1994) N-Acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumour cell extracts. Cancer Res. 54, 3738–3744.
Stadie T. R. E., Chai W., Lawson A. M., Byfield P. G. H., and Hanisch F-G. (1995) Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc:polypeptide N-acetylgalctosaminyltransferase from milk or mammary carcinoma cells. Eur. J. Biochem. 229, 140–147.
Spencer D. I. R., Price M. R., Tendler S. J. B., De Matteis C. I., Stadie T. and Hanisch F.-G. (1996) Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies. Cancer Lett. 100, 11–15.
Price M. R., Hudecz F., O’Sullivan C., Baldwin R. W., Edwards P. M. and Tendler S. J. B. (1990) Immunological and structural features of the protein core of human polymorphic epithelial mucin. Mol. Immunol. 27, 795–802.
Burchell J., Taylor-Papadimitriou J., Boshell M., Gendler S., and Duhig T. (1989) A short sequence, within the amino acid tandem repeat of a cancer associated mucin, contains immunodominant epitopes. Int. J. Cancer 44, 691–696.
Briggs S., Price M. R., and Tendler S. J. B. (1991) Immune recognition of linear epitopes in peptide fragments of epithelial mucins. Immunology 73, 505–507.
Briggs S., Price M. R., and Tendler S. J. B. (1993) Fine specificity of antibody recognition of carcinoma-associated epithelial mucins: antibody binding to synthetic peptide epitopes. Eur. J. Cancer 29A, 230–237.
Davies G. M., Bösze S., Hudecz F., Price M. R., and Tendler S. J. B. (1994) Characterisation of a recombinant Fv fragment of anti-MUC1 antibody HMFG1. Cancer Lett. 82, 179–184.
Denton G., Sekowski M., Spencer D. I. R., Hughes O. D. M., Murray A., Denley H., Tendler S. J. B., and Price M. R. (1997) Production and characterisation of a recombinant anti-MUC1 scFv reactive with human carcinomas. Br. J. Cancer 76, 614–621.
Petrakou E., Graves C. R. L., von Mensdorff-Pouilly S., Robertson J. F. R., and Price M. R. (1997) Preliminary studies on the binding of human autoantibodies to the MUC1 antigen. Int. J. Oncol. 11, 902.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Murray, A., O’Sullivan, D.A., Price, M.R. (2000). Synthetic Peptides for the Analysis and Preparation of Antimucin Antibodies. In: Corfield, A.P. (eds) Glycoprotein Methods and Protocols. Methods in Molecular Biology™, vol 125. Humana Press. https://doi.org/10.1385/1-59259-048-9:129
Download citation
DOI: https://doi.org/10.1385/1-59259-048-9:129
Publisher Name: Humana Press
Print ISBN: 978-0-89603-720-5
Online ISBN: 978-1-59259-048-3
eBook Packages: Springer Protocols